Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism

Thrombosis Research

Volumn 104, Issue 5, 2001, Pages 317-324

  Iglesias Varela, María L ^a   Adamczuk, Yolanda P ^a   Forastiero, Ricardo R ^a,b   Martinuzzo, Marta E ^a,b   Cerrato, Graciela S ^a,b   Pombo, Gonzalo ^a,b   Carreras, Luis O ^a,b  

^a FAVALORO UNIVERSITY   (Argentina)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

Factor V Leiden; Methylenetetrahydrofolate reductase gene; Plasminogen activator inhibitor Type 1 gene; Prothrombin gene mutation; Thrombophilia; Venous thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; COHORT STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTHROMBIN; VENOUS THROMBOSIS;

EID: 0035606959     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00384-X     Document Type: Article

References (28)

1. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
2. Mutation in blood coagulation factor V associated with resistance to activated protein C
3. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
4. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
5. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism
6. 677→Val in the methylenetetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
7. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis
8. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia
9. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
10. World distribution of factor V Leiden
11. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population
12. Geographic distribution of the 20210G to A prothrombin variant
13. 20210 gene variant
14. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
15. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
16. Validated questionnaire for the identification of previous personal or familial venous thromboembolism
17. 2 glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies
18. Rapid detection of the prothrombin 20210A variation by allele specific PCR
19. Prevalence of three prothrombotic polymorphisms: Factor V Leiden, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T in Argentina
20. Contribution of the cystathionine β-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia
21. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to plasma PAI-1 level in venous thromboembolism
22. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease
23. The venous thrombosis risk factor 20210A allele of the prothrombin gene is not a major risk factor for arterial thrombosis disease
24. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives
25. Hyperhomocysteinemia, atherosclerosis and thrombosis
26. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men
27. The A-844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers
28. Familial thrombophilia: A complex genetic disorder